PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 105 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $359,000 | +2.9% | 139,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | +20.8% | 139,900 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $289,000 | -33.3% | 139,900 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $433,000 | +36.2% | 139,900 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $318,000 | -37.2% | 139,900 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $506,000 | -29.5% | 139,900 | -33.7% | 0.00% | 0.0% |
| Q3 2019 | $718,000 | +35.5% | 211,000 | +86.9% | 0.00% | 0.0% |
| Q2 2019 | $530,000 | +51.0% | 112,900 | +7.5% | 0.00% | 0.0% |
| Q1 2019 | $351,000 | +25.8% | 105,000 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $279,000 | -52.6% | 105,000 | 0.0% | 0.00% | -66.7% |
| Q3 2018 | $588,000 | +10.5% | 105,000 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $532,000 | -16.4% | 105,000 | +12.4% | 0.00% | -33.3% |
| Q1 2018 | $636,000 | -25.3% | 93,400 | -17.2% | 0.00% | -25.0% |
| Q4 2017 | $851,000 | +1393.0% | 112,800 | +1028.0% | 0.00% | – |
| Q3 2017 | $57,000 | +14.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $50,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |